Literature DB >> 10894143

Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up.

M G Statius Muller1, P J Borgstein, R Pijpers, P A van Leeuwen, P J van Diest, A Gupta, S Meijer.   

Abstract

BACKGROUND: The sentinel node (SN) concept assumes that early lymphatic metastases, if present, always are found first in the SN. The aim of this study was to determine the reliability of this procedure by establishing the success rate and number of failed procedures during a follow-up period of at least 2 years.
METHODS: From August 1993 to November 1996, 204 consecutive patients with stage I and II cutaneous melanoma underwent SN biopsy by a triple technique. Preoperatively, all patients underwent (dynamic) lymphoscintigraphy. A gamma probe and blue dye helped localize the SN(s) during surgery, and these nodes subsequently were excised. These lymph nodes were step-sectioned and examined by routine and immunohistochemical staining. If the SN contained tumor cells, a lymphadenectomy was performed at a later date.
RESULTS: The median follow-up time was 42 months. The success rate was 99%. Three patients developed a recurrence in the negative SN basin during follow-up, without simultaneous appearance of (locoregional) metastases.
CONCLUSIONS: With a 99% success rate and a 1.5% rate of failed SN procedures (7% false-negative rate) after a median follow-up of 3.5 years, we concluded that the combined triple technique approach of detecting the SN was a reliable method to accurately identify and retrieve the SN.

Entities:  

Mesh:

Year:  2000        PMID: 10894143     DOI: 10.1007/s10434-000-0461-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

Authors:  Torsten Hinz; Hojjat Ahmadzadehfar; Anja Wierzbicki; Tobias Höller; Jörg Wenzel; Hans-Jürgen Biersack; Thomas Bieber; Monika-H Schmid-Wendtner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-08       Impact factor: 9.236

3.  Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma.

Authors:  Alexander Stojadinovic; Peter J Allen; Bryan M Clary; Klaus J Busam; Daniel G Coit
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

4.  How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma.

Authors:  G S Mijnhout; O S Hoekstra; A van Lingen; P J van Diest; H J Adèr; A A Lammertsma; R Pijpers; S Meijer; G J J Teule
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

5.  Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).

Authors:  Melanie A Warycha; Jan Zakrzewski; Quanhong Ni; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Iman Osman
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

6.  Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry.

Authors:  H A Gietema; R J C L M Vuylsteke; I A de Jonge; P A M van Leeuwen; B G Molenkamp; J R M van der Sijp; S Meijer; P J van Diest
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

7.  Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Authors:  Barbara G Molenkamp; Berbel J R Sluijter; Benny Oosterhof; Sybren Meijer; Paul A M van Leeuwen
Journal:  Ann Surg Oncol       Date:  2007-01-17       Impact factor: 5.344

8.  Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry.

Authors:  Alison Beavis; Michael Dawson; Philip Doble; Richard A Scolyer; Roger Bourne; Ling-Xi L Li; Rajmohan Murali; Jonathan R Stretch; Cynthia L Lean; Roger F Uren; John F Thompson
Journal:  Ann Surg Oncol       Date:  2008-01-03       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.